drugset / Trial / NCT00767052
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of multiple ascending oral doses of AZD1236 given to healthy young subjects for 13 days and to evaluate the single-dose relative bioavailability of the oral suspension and oral tablet formulations.
Timeline
- Start
- 2008-09
- Primary completion
- —
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1236 | Small molecule | 75 mg | Oral |
Indications
No indication recorded.